Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin

被引:97
作者
Carlos Hernan, Rodriguez [1 ]
Karina, Bombicino [1 ]
Gabriela, Granados [1 ]
Marcela, Nastro [1 ]
Carlos, Vay [1 ]
Angela, Famiglietti [1 ]
机构
[1] Univ Buenos Aires, Bacteriol Lab, Dept Bioquim Clin, Hosp Clin Jose de San Martin,Fac Farm & Bioquim, RA-1120 Buenos Aires, DF, Argentina
关键词
Acinetobacter; Colistin; Heteroresistance to colistin; POLYMYXIN-B; EMERGENCE; STRAINS;
D O I
10.1016/j.diagmicrobio.2009.05.019
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Colistin heteroresistance in Acinetobacter baumanni (Ab) has been reported, but the clinical impact and the antimicrobial treatment have not been established yet. We observed the selection intratreatment with colistin of Ab colistin-resistant strains from a colistin-heteroresistant isolate in one patient with postneurosurgical meningitis. The presence and the genetic relationship of heteroresistant Ab isolates from intensive care units (ICUs) obtained in the same period of the case report were analyzed. Twenty-eight isolates from patients admitted to the ICUs of an Argentinian university hospital during June to December 2004 were evaluated. Genomoespecie was determined by amplified ribosomal DNA restriction analysis, and genetic similarity among the strains was determined by pulsed-field electrophoresis. Colistin heteroresistance was observed in 46, 4% of these isolates. The majority belonged to clones previously identified as I and Ill. (C) 2009 Published by Elsevier Inc.
引用
收藏
页码:188 / 191
页数:4
相关论文
共 21 条
[1]   In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak [J].
Appleman, MD ;
Belzberg, H ;
Citron, DM ;
Heseltine, PNR ;
Yellin, AE ;
Murray, J ;
Berne, TV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) :1035-1040
[2]  
BANTAR C, 2007, DIAGN MICROBIOL INFE, V60, P65
[3]   Identification of an epidemic carbapenem-resistant Acinetobacter baumannii strain at hospitals in Buenos Aires City [J].
Barbolla, RE ;
Centrón, D ;
Di Martino, A ;
Maimone, S ;
Salgueira, C ;
Famiglietti, A ;
Vay, C ;
Catalano, M .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 45 (04) :261-264
[4]   Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].
BergogneBerezin, E ;
Towner, KJ .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+
[5]  
Clinical and Laboratory Standards Institute, 2018, METH DIL ANT SUSC TE
[6]   Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy [J].
Hawley, Joshua S. ;
Murray, Clinton K. ;
Jorgensen, James H. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (01) :351-352
[7]   Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex [J].
Hawley, Joshua S. ;
Murray, Clinton K. ;
Jorgensen, James H. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (12) :4529-4530
[8]   In-vitro activity of the combination of colistin and rifampicin against multidrug-resistant strains of Acinetobacter baumannii [J].
Hogg, GM ;
Barr, JG ;
Webb, CH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (04) :494-495
[9]  
KOO SK, 2007, J ANTIMICROB CHEMOTH, V60, P1163
[10]   Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro [J].
Kroeger, Lisa A. ;
Hovde, Laurie B. ;
Mitropoulos, Isaac F. ;
Schafer, Jeremy ;
Rotschafer, John C. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (09) :3431-3433